the current advantages and limitations of nk-cell-based therapies
Published 4 months ago • 121 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
2:25
advantages of using car-nks for the treatment of hematological malignancies
-
0:44
nk cells vs t-cells
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:41
an overview of the latest advances in hematology
-
3:02
immune system - natural killer cell
-
5:50
natural killer cell technology | scientific animation
-
10:01
natural killer cells: the tumor killers
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
2:16
current and future treatment approaches for hr-mds
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
2:51
the optimum approach to frontline treatment of cll in 2021
-
19:39
t-cell engagers: targets, challenges and opportunity
-
2:01
hepatic tumor cells and (nk) cell- mediated cytotoxicity | protocol preview
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis
-
2:36
treatment approaches to cll with high-risk molecular features
-
20:14
understanding natural killer cells in cancer immunotherapies
-
8:17
off-the-shelf anti-cd7 car t-cells for t-cell malignancies
-
4:10
how do natural killer cells target cancer?
-
0:24
333 - natural killer